CPB — The Campbell's Company

Is CPB overbought or oversold? Here is the current MarketMoodz read.

Consumer Defensive · Packaged Foods

Overbought As of August 19, 2026

The Campbell's Company (CPB) currently reads Overbought on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The Consumer Defensive name (Packaged Foods) last closed at $23.81. The rating moved from Neutral to Overbought on August 6, 2026.

See all overbought Consumer Defensive stocks →

AI analysis

The Campbell's Company (CPB) is a defensive packaged-food franchise with stable cash flow and a history of returning capital to shareholders. Near-term upside is constrained by modest organic growth prospects and potential cost pressures from ingredient reformulation and commodity volatility, while margin programs and operational improvements offer offsetting support. Sector dynamics—investor preference for defensive names and heightened scrutiny on clean-label reformulation—suggest earnings could be stable but not rapidly accelerating; outcomes hinge on execution of cost savings, successful product innovation, and the company’s ability to navigate regulatory and input-cost changes. Scenarios range from steady cash-flow stability with modest share-price upside if margin plans hold, to earnings pressure if reformulation and input-costs accelerate or retail customers push pricing.

Key factors

  • Well-known, diversified branded portfolio with resilient, defensive consumption patterns
  • Stable cash flows and shareholder return history (dividends / buybacks) support valuation floor
  • Limited near-term organic growth catalysts; growth dependent on SKU innovation and premium/snacking adjacencies
  • Exposure to sector themes: clean-label reformulation may force reformulation-related costs and supply shifts
  • Potential cost savings from ongoing supply‑chain/operations initiatives and productivity programs
  • Defensive sector positioning benefits from risk-off rotation and stable retail demand

Risks

  • Regulatory change (GRAS/clean-label) increasing reformulation costs and substituting ingredients
  • Commodity, packaging and freight cost volatility compressing margins if not fully passed-through
  • Intense private-label competition and retail buyer pricing pressure
  • Execution risk on margin-improvement and innovation initiatives
  • Macro-driven demand weakness or retailer inventory reductions that hit top-line growth
  • Limited visibility from current public filings and social/research signals in the provided window

Latest MarketMoodz coverage

See today's live rating, score and targets

Members see the live hourly rating for CPB — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.